The global Sterile Injectables CDMO Market was valued at USD 37.8 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 87.3 billion by 2033, expanding at a CAGR of 11.2% from 2026 to 2033. North America accounted for the largest revenue share of 33.7% in 2025, supported by the presence of leading pharmaceutical manufacturers, strong biologics pipelines, and...